In the BioHarmony Drug Report Database
Mexiletine
Mexitil, Namuscla (mexiletine) is a small molecule pharmaceutical. Mexiletine was first approved as Mexitil on 1985-12-30. It is used to treat cardiac arrhythmias, diabetic neuropathies, ventricular fibrillation, and ventricular premature complexes in the USA. It has been approved in Europe to treat myotonic disorders. The pharmaceutical is active against sodium channel protein type 4 subunit alpha.
Trade Name
|
Namuscla |
|---|---|
Common Name
|
mexiletine |
ChEMBL ID
|
CHEMBL558 |
Indication
|
cardiac arrhythmias, diabetic neuropathies, myotonic disorders, ventricular fibrillation, ventricular premature complexes |
Drug Class
|
Image (chem structure or protein)